No more paracetamol and oxycodone tablets shall be purchased by unqualified enterprises since September

Drug administration, health and Health Commission of all provinces, autonomous regions and municipalities directly under the central government, drug administration and Health Commission of Xinjiang production and Construction Corps: Recently, the State Food and drug administration, the Ministry of public security and the state health and Health Commission jointly issued the announcement on the inclusion of compound preparations containing oxycodone in the management of psychotropic drugs, which will come into effect on September 1, 2019 Now, the production, operation and use of paracetamol oxycodone tablets are notified as follows: 1、 The manufacturer of paracetamol and oxycodone tablets shall, in accordance with the requirements of the administrative measures for the production of narcotic drugs and psychotropic substances (Trial) (gsyjja [2005] No 528), be equipped with the storage conditions and safety management facilities that meet the requirements, formulate the corresponding management system, and apply to the local provincial drug supervision and administration department for going through the designated production procedures before January 1, 2020 2、 As of January 1, 2020, the production and import of paracetamol oxycodone tablets must be printed with the specified marks on their packages and instructions The products previously produced and imported can continue to circulate and use within the validity period The modification of drug labels and instructions shall be handled in accordance with the relevant provisions of the measures for the administration of drug registration 3、 Since September 1, 2019, enterprises without the qualification for the second category of psychotropic drugs shall not purchase any more paracetamol oxycodone tablets, and the original inventory products shall be registered and reported to the local municipal people's government with the responsibility of drug supervision and management for the record, and sold out as required 4、 From September 1, 2019, medical institutions shall, in accordance with the regulations on the administration of narcotic drugs and psychotropic substances and other relevant regulations, strengthen the management of paracetamol and oxycodone tablets, and issue paracetamol and oxycodone tablets with special prescriptions for psychotropic drugs The single prescription shall not exceed 7 daily dosage The drug regulatory departments and health departments at all levels shall earnestly perform their duties, strengthen the supervision of the production, operation and use of paracetamol oxycodone tablets, urge the relevant units to strictly implement the above provisions, ensure the medical demand, and prevent it from flowing into illegal channels State Food and Drug Administration National Health and Health Commission August 21, 2019